Newly published studies today include data on:
- Risk for patients with prostate atypia on biopsy having a subsequent diagnosis of prostate cancer
- Patterns of failure of patients treated with brachytherapy for localized disease
- Quality of life following differing types of radiotherapy
- Second-line antiandrogen therapy following initial failure of a first-line antiandrogen in advanced prostate cancer
- Mood and cognitive changes in men receiving intermittent androgen deprivation therapy … MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: androgen deprivation, antiandrogen, atypia, bicalutamide, brachytherapy, cancer, depression, fatigue, flutamide, irritability, mood, prostate, quality of life, radiotherapy | Leave a comment »
THE "NEW" PROSTATE CANCER INFOLINK 